Jessie Hao-Ru Hsu,Benjamin Hubbell-Engler,Guillaume Adelmant,Jialiang Huang,Cailin E. Joyce,Francisca Vazquez,Barbara A. Weir,Philip Montgomery,Aviad Tsherniak,Andrew O. Giacomelli,Jennifer A. Perry,Jennifer Trowbridge,Yuko Fujiwara,Glenn S. Cowley,Huafeng Xie,Woojin Kim,Carl D. Novina,William C. Hahn,Jarrod A. Marto,Stuart H. Orkin

Abstract:AbstractThrough an shRNA screen, we identified the protein arginine methyltransferase Prmt1 as a vulnerable intervention point in murine p53/Rb-null osteosarcomas, the human counterpart of which lacks effective therapeutic options. Depletion of Prmt1 in p53-deficient cells impaired tumor initiation and maintenance in vitro and in vivo. Mechanistic studies reveal that translation-associated pathways were enriched for Prmt1 downstream targets, implicating Prmt1 in translation control. In particular, loss of Prmt1 led to a decrease in arginine methylation of the translation initiation complex, thereby disrupting its assembly and inhibiting translation. p53/Rb-null cells were sensitive to p53-induced translation stress, and analysis of human cancer cell line data from Project Achilles further revealed that Prmt1 and translation-associated pathways converged on the same functional networks. We propose that targeted therapy against Prmt1 and its associated translation-related pathways offer a mechanistic rationale for treatment of osteosarcomas and other cancers that exhibit dependencies on translation stress response. Cancer Res; 77(17); 4613–25. ©2017 AACR.

Supplementary Figures and Legends from PRMT1-Mediated Translation Regulation is a Crucial Vulnerability of Cancer

Supplementary Table 3 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer

Supplementary Table 2 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer

Supplementary Table 1 from PRMT1-Mediated Translation Regulation is a Crucial Vulnerability of Cancer

Supplementary Table 4 from PRMT1-Mediated Translation Regulation is a Crucial Vulnerability of Cancer

Supplementary Table 5 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer

Data from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer

Prmt1-Mediated Translation Regulation Is A Crucial Vulnerability Of Cancer

Supplementary Figure and Table Legends from A Diverse Array of Cancer-Associated <i>mtor</i> Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary Table 5 from A Diverse Array of Cancer-Associated <i>MTOR</i> Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary Figures from AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells

Supplementary Data from the RNA M6a Reader YTHDF2 Maintains Oncogene Expression and is a Targetable Dependency in Glioblastoma Stem Cells

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table S1-S20 from Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia

Supplementary Methods and Figure S1-S12 from Mutant U2AF1-Induced Mis-Splicing of Mrna Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia

Supplementary Methods, Figures S1 - S14, Tables S1, S3 - S10 from A Large-Scale RNAi-Based Mouse Tumorigenesis Screen Identifies New Lung Cancer Tumor Suppressors That Repress FGFR Signaling

Supplementary Figure S3 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Figure Legends from Modulation of Gene Expression in Human Central Nervous System Tumors under Methionine Deprivation-induced Stress

Supplementary Figure 6 from A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary Figure 1 from A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary file from Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy